IO Biotech (IOBT)
NASDAQ:IOBT
US Market
Holding IOBT?
Track your performance easily

IO Biotech (IOBT) Financial Statements

253 Followers

IO Biotech Financial Overview

IO Biotech's market cap is currently ―. The company's EPS TTM is $-1.438; its P/E ratio is -0.76; IO Biotech is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -20.29M$ -19.04M$ -25.83M$ -22.12M$ -20.68M
EBITDA$ -20.07M$ -18.83M$ -25.63M$ -21.92M$ -20.49M
Net Income Common Stockholders$ -20.69M$ -19.46M$ -26.18M$ -21.68M$ -21.18M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 100.75M$ 117.98M$ 143.19M$ 165.50M$ 110.09M
Total Assets$ 111.47M$ 128.16M$ 150.72M$ 172.55M$ 117.56M
Total Debt$ 2.15M$ 2.32M$ 2.49M$ 2.60M$ 2.77M
Net Debt$ -98.60M$ -115.67M$ -140.70M$ -162.90M$ -107.32M
Total Liabilities$ 15.20M$ 12.69M$ 17.56M$ 14.96M$ 13.04M
Stockholders Equity$ 96.27M$ 115.47M$ 133.16M$ 157.59M$ 104.52M
Cash Flow-
Free Cash Flow$ -16.99M$ -24.94M$ -22.91M$ -16.01M$ -18.30M
Operating Cash Flow$ -16.98M$ -24.93M$ -22.80M$ -15.99M$ -18.26M
Investing Cash Flow$ -12.00K$ -11.00K$ -112.00K$ -24.00K$ -39.00K
Financing Cash Flow--$ -10.00K$ 71.87M-
Currency in USD

IO Biotech Earnings and Revenue History

IO Biotech Debt to Assets

IO Biotech Cash Flow

IO Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis